Diabetes Mellitus, Type 2 Clinical Trials

60 studies are recruiting for diabetes mellitus, type 2 in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 2

  1. A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

    The main objective of this trial is to assess the safety and tolerability of AMG 127 as single dose and multiple doses in healthy participants and participants with type 2 diabetes mellitus (T2DM).

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Orange County Research Center, Lake Forest, California
    Locations
    2 in total
    Run by
    Amgen
  2. Re-Engineered Discharge for Diabetes Care Transitions

    The goal of this project is to test a novel bedside SDOH screening intervention coupled with post-discharge navigation for hospitalized patients with a diabetes diagnosis to reduce unmet social needs, compared to usual care.

    Stage
    Not phased
    Ages
    18 and older
    Site
    UMASS Memorial Healthcare System, Worcester, Massachusetts
    Run by
    University of Massachusetts, Worcester
  3. Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. While weight loss through lifestyle modification is the standard treatment, most patients regain weight limiting ultimate improvement in liver disease. On the other end of the spectru…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Brigham and Women's Hospital, Boston, Massachusetts
    Locations
    2 in total
    Run by
    Pichamol Jirapinyo, MD, MPH
  4. OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)

    The goal of this clinical trial is to compare the effects of peer coaching models in older adults with unmanaged type two diabetes. The main questions it aims to answer are: * Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management? * If effective, which facets of t…

    Stage
    Not phased
    Ages
    55 and older
    Site
    Barren River Area Development District, Bowling Green, Kentucky
    Locations
    2 in total
    Run by
    The University of Texas Medical Branch, Galveston
  5. OASIS: Peer Support for T2DM in Appalachia (Peer Participant)

    The goal of this clinical trial is to compare the effects of peer coaching models in older adults with unmanaged type two diabetes. The main questions it aims to answer are: * Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management? * If effective, which facets of t…

    Stage
    Not phased
    Ages
    55 and older
    Site
    Barren River Area Development District, Bowling Green, Kentucky
    Locations
    2 in total
    Run by
    The University of Texas Medical Branch, Galveston
  6. Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

    The goal of this randomized controlled trial is to compare the efficacy and safety of the iLet Bionic Pancreas (BP) System in adults with insulin-treated diabetes (type 1 diabetes or type 2 diabetes) compared to standard of care when ordered by primary care providers. The main question it aims to a…

    Stage
    Not phased
    Ages
    18 to 89
    Site
    University of Colorado Anschutz Medical Campus, Aurora, Colorado
    Locations
    2 in total
    Run by
    University of Colorado, Denver
  7. Glucose and Activity Tracking for Sedentary Behavior Interventions in Older People With Type 2 Diabetes (TRACK T2D)

    The overarching goal of this explanatory mixed methods study is to evaluate how older people living with type 2 diabetes (T2D) integrate continuous glucose monitor (CGM) and activity data in diabetes self-management, and how this technology supports reduced sedentary behavior (SB) and improved gluc…

    Stage
    Not phased
    Ages
    55 and older
    Site
    University of Minnesota, Minneapolis, Minnesota
    Run by
    University of Minnesota
  8. Milk for Diabetes Prevention

    Individuals with lactase non-persistence (LNP; determined by a functional variant in the LCT gene [rs4988235, GG genotype]) are susceptible to lactose intolerance in adulthood due to deficiency of lactase, the enzyme which digests milk lactose sugars. However, many LNP individuals still drink ≥1 cu…

    Stage
    Not phased
    Ages
    18 to 70
    Site
    HCHS/SOL Bronx Field Center, The Bronx, New York
    Run by
    Albert Einstein College of Medicine
  9. Mixed Methods Study of Health-Related Social Needs in African American Adults With Chronic Kidney Disease and Type 2 Diabetes Mellitus

    The overarching goal of this study is to understand facilitators and barriers to self-care, develop and refine a culturally tailored intervention to improve clinical outcomes, quality of life (QOL), and self-care behaviors in African American adults with diabetic kidney disease (DKD) experiencing h…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Medical College of Wisconsin, Milwaukee, Wisconsin
    Run by
    Medical College of Wisconsin
  10. Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

    Sixteen institutions will be selected from a HRSA uniform data system and have data collected for up to 3 years. Eight institutions will begin the iPATH practice transformation during year one, the other eight institutions will begin iPATH in year two. FQHC administrators, clinicians and staff will…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Board of Trustees of the Leland Stanford Junior University, Stanford, California
    Locations
    4 in total
    Run by
    Stanford University
  11. Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature

    A prospective, multicenter evaluation of performance and safety of the Eversense Gemini System with flash glucose measurement feature. The purpose of this clinical investigation is to evaluate the accuracy of the Gemini System with new technological flash glucose monitoring (FGM) feature enhancemen…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Headlands Research - AMCR Institute, Escondido, California
    Run by
    Senseonics, Inc.
  12. ROME GS System Study

    The purpose of this clinical investigation is to demonstrate that the proposed physical changes to the ROME GS Sensor do not have any adverse impact on safety and performance when compared to the Eversense 365 Sensor.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Headlands Research - AMCR Institute, Escondido, California
    Locations
    4 in total
    Run by
    Senseonics, Inc.
  13. Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide

    This study is to investigate how adipocyte (fat cell) function and fat distribution differ between individuals with normal-weight type 2 diabetes (NWD), those with overweight type 2 diabetes (OWD), and normal-weight controls without diabetes (NWC). The study will assess whether adipocyte-directed t…

    Stage
    Phase 4
    Ages
    30 to 70
    Site
    Stanford University, Palo Alto, California
    Locations
    2 in total
    Run by
    Stanford University
  14. Boosting Emotional Well-being and Happiness in Outpatients Living With Diabetes

    The focus of this study is to test the efficacy of an 8-week, remotely delivered, positive-psychology-motivational interviewing (PP-MI) intervention, with additional twice weekly text messages for a total of 16 weeks (with interactive, algorithm-driven, goal-focused text messages in the final 8 wee…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Massachusetts General Hospital, Boston, Massachusetts
    Run by
    Massachusetts General Hospital
  15. Project Dulce for Arab Americans With Type 2 Diabetes

    Arab Americans (AA) face many challenges in diabetes self-management due to the limited educational resources and support available for them. The cultural and linguistic barriers between patients and health care providers lead to poor diabetes management and outcomes. This study (Project Dulce Arab…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Metro Caring, Denver, Colorado
    Locations
    2 in total
    Run by
    Scripps Whittier Diabetes Institute
  16. Transformative Research in Diabetic Nephropathy 2.0

    The goal of this observational study is to learn more about kidney health in adults with diabetic kidney disease and other groups. Researchers will study kidney tissue and other samples. They want to learn how sodium-glucose cotransporter-2 (SGLT2) inhibitors, a type of diabetes medicine, may affec…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Penn Presbyterian Medical Center, Philadelphia, Pennsylvania
    Run by
    University of Pennsylvania
  17. Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes

    The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on health behavior-focused messages delivered through the app. The study will enroll English-speaking…

    Stage
    Not phased
    Ages
    16 to 24
    Site
    Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania
    Run by
    University of Pittsburgh
  18. Blood Markers of Early Pancreas Cancer

    Identifying biomarkers of early pancreatic ductal adenocarcinoma (PDAC) could facilitate screening for individuals at higher than average risk and expedite the diagnosis in individuals with symptoms and substantially improve an individual's chance of surviving the disease. The investigators propose…

    Stage
    Not phased
    Ages
    19 and older
    Site
    Unversity of Nebraska Medical Center, Omaha, Nebraska
    Run by
    University of Nebraska
  19. Use of CGM in Kidney Transplant Recipients

    The investigators want to study the impact CGM (continuous glucose monitoring) has on patients glycemic control as determined by time in range (TIR 70-180 mg/dL) in the Diabetic Kidney Transplant population.

    Stage
    Not phased
    Ages
    18 and older
    Site
    UC Davis Health, Sacramento, California
    Run by
    University of California, Davis
  20. Drug Interaction Potential of Pro-Inflammatory Conditions

    Pro-inflammatory cytokines, which are elevated in pro-inflammatory disease states (e.g., type II diabetes mellitus [T2DM], irritable bowel diseases [IBD], and end stage renal disease [ESRD]) have been shown to inhibit hepatic drug-metabolizing enzymes, including members of the cytochrome P450 (CYP)…

    Stage
    Not phased
    Ages
    12 to 99
    Site
    Indiana University Hospital, Indianapolis, Indiana
    Run by
    Indiana University
  21. Improving Diabetes Care With Strategies For Addressing Health-Related Social Needs and Community Partnerships

    The goal of this study is to develop, implement, and evaluate a patient-centered triage and referral model designed to improve health outcomes for individuals with uncontrolled type 2 diabetes mellitus (T2DM) and unmet health-related social needs. The intervention builds on the existing THRIVE infr…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Boston Medical Center, Boston, Massachusetts
    Run by
    Boston Medical Center
  22. Family Model DSME in FBOs in the RMI

    Health disparities in the Republic of the Marshall Islands are striking, with extremely high rates of type 2 diabetes. Documented prevalence of type 2 diabetes in the Marshall Islands ranges from 20%-50%.This is significantly higher than the global (8.5%) and United States (11%) prevalence. Diabete…

    Stage
    Not phased
    Ages
    18 and older
    Site
    UAMS Institute for Community Health Innovation, Springdale, Arkansas
    Run by
    University of Arkansas
  23. Post Prandial Individual Responses to Different Foods

    This study aims to understand why people respond differently to the same foods, especially when it comes to changes in blood sugar after eating. A continuous glucose monitors (CGMs) will be used to observe how individuals respond to specific meals and drinks (e.g., Oral Glucose Tolerance Test, OGTT…

    Stage
    Not phased
    Ages
    18 to 80
    Site
    Stanford University, Stanford, California
    Run by
    Stanford University
  24. SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease

    Peripheral arterial disease (PAD) affects over 230 million adults worldwide and is a highly morbid, costly, and disabling condition. Ischemic leg pain drives disability in PAD patients and results from oxygen supply-demand mismatch, autonomic dysfunction, and muscle breakdown. This leg pain, which …

    Stage
    Not phased
    Ages
    19 to 89
    Site
    University of Nebraska Medical Center, Omaha, Nebraska
    Run by
    University of Nebraska
  25. Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)

    This is a pragmatic randomized controlled trial (pRCT) that aims to test the effect of produce provision, diabetes education, and community referrals on hemoglobin A1c levels in individuals with type 2 diabetes experiencing food insecurity.

    Stage
    Not phased
    Ages
    18 and older
    Site
    The Ohio State University Wexner Medical Center, Columbus, Ohio
    Run by
    Ohio State University

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.